新西兰系统性红斑狼疮的死亡率及死因:一项基于人群的研究
该研究基于2005至2021年新西兰全国行政数据集,纳入2802例系统性红斑狼疮(SLE)患者,分析其死亡率、死因及不同亚组间的差异。结果显示SLE患者死亡风险为一般人群的4倍(SMR 4.0),毛利人全因死亡和SLE特异性死亡风险均高于其他人。
要点
- SLE患者全因死亡风险为一般人群的4倍(SMR 4.0;95%CI 3.7, 4.3)。
- 年轻患者SMR更高,且更常以SLE为根本死因。
- 毛利人全因死亡(HR 1.72)和SLE特异性死亡(HR 2.60)风险均高于其他人。
核心结论
- 与一般人群相比,新西兰SLE患者的结局仍然很差。
- 毛利人SLE患者的生存情况差于其他人。
- 需要进一步研究以确定这种差异的原因。
研究设计与样本
- 研究基于2005至2021年新西兰全国行政数据集识别SLE患者,并检查其根本死因。
- 采用标准化死亡比(SMR)比较SLE患者观察死亡数与一般人群预期死亡数。
- 采用Cox比例风险模型,在按年龄调整后估计不同族裔的全因死亡和SLE特异性死亡的风险比(HR)及95%置信区间(CI)。
主要发现
- 纳入分析的2802例患者中,699例(24.9%)死亡,其中209例(29.9%)为SLE死亡。
- SLE的年龄标准化死亡率女性为0.29/10万,男性为0.05/10万。
- 死亡平均年龄为65.3(17.1)岁。
- 年轻患者更可能以SLE为根本死因,20岁以下者为78.9%,70-79岁者为18.7%。
- 与一般人群相比,SLE患者死亡可能性为4倍(SMR 4.0;95%CI 3.7, 4.3),年轻患者SMR高于老年患者。
关键数值与推荐
- 毛利人全因死亡HR为1.72(95%CI 1.10, 2.67),高于其他人。
- 毛利人SLE特异性死亡HR为2.60(95%CI 1.29, 5.24),高于其他人。
局限性
- 原文指出需要进一步研究以确定毛利人与其他人之间生存差异的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aims to assess the mortality of systemic lupus erythematosus (SLE) patients and examine whether there are variations by subgroup. METHODS: SLE patients from 2005 to 2021 were identified from the national administrative datasets. The underlying causes of death were examined. Standardized mortality ratio (SMR) was estimated to compare the relative rate of observed deaths in SLE patients with expected deaths in the general population. The hazard ratios (HR) and 95% confidence intervals (CI) of all-cause mortality and SLE specific mortality by ethnicity were estimated after adjustment for age using a Cox proportional hazards model. RESULTS: Of the 2802 patients included for analysis, 699 (24.9%) died with 209 (29.9%) SLE deaths. The age-standardized mortality rate of SLE was 0.29 per 100 000 for women and 0.05 for men. The mean age at death was 65.3 (17.1) years. Younger patients were more likely to have SLE as the underlying cause of death, from 78.9% for those under 20 years old to 18.7% for those aged 70-79 years. Compared with the general population, SLE patients were four times more likely to die (SMR: 4.0; 95% CI: 3.7, 4.3). Young patients had higher SMRs than older patients. Māori had worse all-cause mortality (HR: 1.72; 95% CI: 1.10, 2.67) and SLE specific mortality (HR: 2.60; 95% CI: 1.29, 5.24) than others. CONCLUSIONS: The outcomes of SLE in New Zealand were still very poor compared with the general population. Māori with SLE had worse survival than others. Further research is needed to identify the reasons for this disparity.
引用
- Lao C, White D, Rabindranath K, et al. Mortality and causes of death in systemic lupus erythematosus in New Zealand: a population-based study. Rheumatology (Oxford). 2024. PMID: 37632770. doi:10.1093/rheumatology/kead427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。